Skip to menu Skip to content Skip to footer
Professor Mark Smithers
Professor

Mark Smithers

Email: 

Overview

Background

Emeritus Professor Mark Smithers is a surgical oncologist who specialises in surgery for oesophago-gastric diseases, melanoma, advanced skin cancer and soft tissue sarcoma. He was the Director of the Upper GI and Soft Tissue Unit at the Princess Alexandra Hospital, in Brisbane, Australia from 1998 - 2023. Commencing his academic career with the University of Queensland in 1987, he progressed to be the Mayne Chair in Surgery and head of the Academy of Surgery. He is the second University of Queensland Medical graduate to be appointed to this role. His research has been focussed on the development and assessment of outcomes from minimally invasive upper GI surgery, and trials assessing the role of perioperative multidisciplinary therapy for esophageal and gastric cancer. As well he has led, or been involved with, clinical trials from phase I to III, for all stages of melanoma through his role as the Chair of the Queensland Melanoma Project. More recently he has been involved with the assessment of access to, and outcomes from, surgery for cancer in Queensland, Australia.

He has overseen the administration and development of the surgery curriculum, and the teaching, in the Academy of Surgery, in the UQ Faculty of Medicine. He was on a number of committees relevant to the implementation of the UQ MD design course. He has held various leadership and committee roles with the Royal Australasian College of Surgeons, as well as leadership roles, including the Presidency, in the Australian and New Zealand Oesophago Gastric Surgeons Association. He has also been on the committees of international organisations related to oesophageal and gastric surgery. He has published 250 articles, eight book chapters, and has been on the editorial board of a number of surgical journals.

He has been recognised for his clinical and academic roles by the award of Member of the Order of Australia (AM). The citation reads, "for service to medicine in the fields of gastro-intestinal and melanoma surgery, to medical education and to professional organisations". The Royal Australasian College of Surgeons awarded him the Sir Hugh Devine medal, for services to surgery and the community. This is the College’s highest honour. Internationally, he has been awarded an honorary fellowship of the Royal College of Surgeons of Edinburgh and recently, in the United States, he was elected as an Honarary Fellow of the American Surgical Association.

Availability

Professor Mark Smithers is:
Not available for supervision
Media expert

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Honorary Fellow, American Surgical Association, American Surgical Association
  • Fellow, Royal Australasian College of Surgeons, Royal Australasian College of Surgeons
  • Fellow, Royal College of Surgeons of Edinburgh, Royal College of Surgeons of Edinburgh
  • Fellow, Royal College of Surgeons of England, Royal College of Surgeons of England

Research interests

  • Cutaneous Melanoma

    epidemiology, public health issues and management of all stages

  • Management of Oesophageal and Gastric Cancer

    Investigation and management of benign and malignant diseases of the oesophagus and the stomach.

Works

Search Professor Mark Smithers’s works on UQ eSpace

410 works between 1983 and 2025

1 - 20 of 410 works

2025

Journal Article

Textbook outcomes for retroperitoneal sarcoma resection: a multi-centre review

Murphy, Skyle, Allan, Christopher, Barbour, Andrew, Donoghue, Victoria and Smithers, B. Mark (2025). Textbook outcomes for retroperitoneal sarcoma resection: a multi-centre review. Current Oncology, 32 (6) 364, 1-17. doi: 10.3390/curroncol32060364

Textbook outcomes for retroperitoneal sarcoma resection: a multi-centre review

2025

Journal Article

3890 Intercontinental Perspectives on Oligometastasis in Esophageal and Gastric Cancer: A Comparative Study with European Findings

Bronzwaer, Sebastiaan F.C., Kroese, Tiuri E., Smithers, B. Mark, Kang, Chang Hyun, Yang, Han Kwang, Hyung, Woo Jin, Daiko, Hiroyuki, Terashima, Masanori, Kinoshita, Takahiro, Hofstetter, Wayne, Mansfield, Paul, Badgewell, Brian, Strong, Vivian E., Sarkaria, Inderpal, Ferri, Lorenzo, Sallum, Rubens A.A., Nieponice, Alejandro, Navarette, Andres, Ruurda, Jelle P., van Laarhoven, Hanneke W.M., van Rossum, Peter S.N. and van Hillegersberg, Richard (2025). 3890 Intercontinental Perspectives on Oligometastasis in Esophageal and Gastric Cancer: A Comparative Study with European Findings. Radiotherapy and Oncology, 206, S1846-S1848. doi: 10.1016/s0167-8140(25)02032-8

3890 Intercontinental Perspectives on Oligometastasis in Esophageal and Gastric Cancer: A Comparative Study with European Findings

2025

Journal Article

Pathological response guides adjuvant 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy in surgically resected gastro-oesophageal cancer (SPACE-FLOT): international cohort study

SPACE-FLOT Investigators and Smithers, Mark (SPACE-FLOT Investigator) (2025). Pathological response guides adjuvant 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy in surgically resected gastro-oesophageal cancer (SPACE-FLOT): international cohort study. British Journal of Surgery, 112 (4) znaf056. doi: 10.1093/bjs/znaf056

Pathological response guides adjuvant 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy in surgically resected gastro-oesophageal cancer (SPACE-FLOT): international cohort study

2025

Journal Article

Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy

Cabrit, Nicolas, Cheugoua-Zanetsie, Maurice, Tierney, Jayne, Thirion, Pierre, Nankivell, Matthew, Winter, Kathryn, Yang, Hong, Wijnhoven, Bas, Vernerey, Dewi, Smithers, B.Mark, Piessen, Guillaume, Nilsson, Magnus, Boonstra, Jurjen, Ychou, Marc, Law, Simon, Cunningham, David, Vathaire, Florent de, Stahl, Michael, Urba, Susan, Valmasoni, Michele, Williaume, Danièle, Thomas, Janine, Lordick, Florian, Tepper, Joel, Gebski, Val, Burmeister, Bryan, Paoletti, Xavier, Sandick, Johanna van, Fu, Jianhua ... Michiels, Stefan (2025). Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy. European Journal of Cancer, 218 115292, 115292. doi: 10.1016/j.ejca.2025.115292

Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy

2025

Journal Article

Prognostic markers could extend adjuvant immunotherapy to high-risk Stage IB/IIA melanoma: a modelling study

Tan, Samuel X., Muller, Nicholas, Zhou, Chenhao, Walpole, Euan, Smithers, B. Mark, Whiteman, David C. and Khosrotehrani, Kiarash (2025). Prognostic markers could extend adjuvant immunotherapy to high-risk Stage IB/IIA melanoma: a modelling study. JAAD International, 18, 86-87. doi: 10.1016/j.jdin.2024.09.010

Prognostic markers could extend adjuvant immunotherapy to high-risk Stage IB/IIA melanoma: a modelling study

2024

Journal Article

Preoperative chemoradiotherapy for resectable gastric cancer

Leong, Trevor, Smithers, B. Mark, Michael, Michael, Haustermans, Karin, Wong, Rebecca, Gebski, Val, O’Connell, Rachel L., Zalcberg, John, Boussioutas, Alex, Findlay, Michael, Willis, David, Moore, Alisha, Murray, William K., Lordick, Florian, O’Callaghan, Chris, Swallow, Carol, Darling, Gail, Miller, Danielle, Strickland, Andrew, Liberman, Moishe, Mineur, Laurent and Simes, John (2024). Preoperative chemoradiotherapy for resectable gastric cancer. The New England Journal of Medicine, 391 (19), 1810-1821. doi: 10.1056/nejmoa2405195

Preoperative chemoradiotherapy for resectable gastric cancer

2024

Conference Publication

A Randomised, Placebo-Controlled, Phase II Trial of Adjuvant Avelumab in Patients with Stage I-III Merkel Cell Carcinoma

Xu, Wen, Poulsen, Michael, Atkinson, Victoria, Fogarty, Gerald, Veness, Michael, Smithers, Bernard, Gyorki, David, Mar, Victoria and Guminski, Alexander (2024). A Randomised, Placebo-Controlled, Phase II Trial of Adjuvant Avelumab in Patients with Stage I-III Merkel Cell Carcinoma. Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, Sydney, NSW Australia, 14-16 August 2024. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.14111

A Randomised, Placebo-Controlled, Phase II Trial of Adjuvant Avelumab in Patients with Stage I-III Merkel Cell Carcinoma

2024

Journal Article

Quality performance indicators for oesophageal and gastric cancer: ANZ expert Delphi consensus

Kulasegaran, Suheelan, Woodhouse, Braden, Wang, Yijiao, Siddaiah‐Subramanya, Manjunath, Merrett, Neil, Smithers, Bernard Mark, Watson, David, MacCormick, Andrew, Srinivasa, Sanket and Koea, Jonathan (2024). Quality performance indicators for oesophageal and gastric cancer: ANZ expert Delphi consensus. ANZ Journal of Surgery, 94 (10), 1732-1737. doi: 10.1111/ans.19173

Quality performance indicators for oesophageal and gastric cancer: ANZ expert Delphi consensus

2024

Conference Publication

A randomized phase III trial of perioperative chemotherapy (periop CT) with or without preoperative chemoradiotherapy (preop CRT) for resectable gastric cancer (AGITG TOPGEAR): Final results from an intergroup trial of AGITG, TROG, EORTC and CCTG

Leong, T., Smithers, B.M., Michael, M., Haustermans, K.M., Wong, R., Gebski, V., O'Connell, R., Zalcberg, J.R., Boussioutas, A., Findlay, M., Willis, D., Moore, A., Lordick, F., O'Callaghan, C., Swallow, C., Darling, G.E., Strickland, A., Liberman, M., Mineur, L. and Simes, J. (2024). A randomized phase III trial of perioperative chemotherapy (periop CT) with or without preoperative chemoradiotherapy (preop CRT) for resectable gastric cancer (AGITG TOPGEAR): Final results from an intergroup trial of AGITG, TROG, EORTC and CCTG. ESMO Congress 2024, Barcelona, Spain, 13-17 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2024.08.2300

A randomized phase III trial of perioperative chemotherapy (periop CT) with or without preoperative chemoradiotherapy (preop CRT) for resectable gastric cancer (AGITG TOPGEAR): Final results from an intergroup trial of AGITG, TROG, EORTC and CCTG

2024

Conference Publication

Alterations In Local Oesophageal Microbiota And Outcomes After Oesophagectomy For Oesophago-gastric Cancer: A Pilot Study

Stokes, Matthew, (Frank) Yu, Zirong, Schlebusch, Sanmarie, Jennison, Amy, Graham, Rikki, Cooper, Caroline, Smithers, B. Mark, Barbour, Andrew, Thomson, Iain and Frankel, Adam (2024). Alterations In Local Oesophageal Microbiota And Outcomes After Oesophagectomy For Oesophago-gastric Cancer: A Pilot Study. 20th ISDE World Congress for Esophageal Diseases, Edinburgh, United Kingdom, 22 - 24 September 2024. Cary, NC United States: Oxford University Press. doi: 10.1093/dote/doae057.006

Alterations In Local Oesophageal Microbiota And Outcomes After Oesophagectomy For Oesophago-gastric Cancer: A Pilot Study

2024

Journal Article

Achieving a textbook outcome in patients undergoing gastric resections in a low incidence, high volume Australian Upper GI unit

Bouffler, Clare, King, Sarah, Frankel, Adam, Barbour, Andrew, Scott, Justin, Thomas, Janine, Smithers, B. Mark and Thomson, Iain (2024). Achieving a textbook outcome in patients undergoing gastric resections in a low incidence, high volume Australian Upper GI unit. Journal of Gastrointestinal Surgery, 28 (9), 1436-1442. doi: 10.1016/j.gassur.2024.06.005

Achieving a textbook outcome in patients undergoing gastric resections in a low incidence, high volume Australian Upper GI unit

2024

Journal Article

Complications and adverse events in lymphadenectomy of the inguinal area: worldwide expert consensus

Sotelo, René, Sayegh, Aref S., Medina, Luis G., Perez, Laura C., La Riva, Anibal, Eppler, Michael B., Gaona, José, Tobias-Machado, Marcos, Spiess, Philippe E., Pettaway, Curtis A., Lima Pompeo, Antonio Carlos, Lima Mattos, Pablo Aloisio, Wilson, Timothy G., Villoldo, Gustavo M., Chung, Eric, Samaniego, Aldo, Ornellas, Antonio Augusto, Pinheiro, Vladimir, Brazão, Eder S., Subira-Rios, David, Koifman, Leandro, Zequi, Stênio de Cassio, Pontillo Z, Humberto M., Rodrigues Calixto, José de Ribamar, Campos Silva, Rafael, Smithers, B. Mark, Garzon, Simone, Haase, Oliver, Sommariva, Antonio ... Cacciamani, Giovanni E. (2024). Complications and adverse events in lymphadenectomy of the inguinal area: worldwide expert consensus. BJS Open, 8 (4) zrae056, 1-8. doi: 10.1093/bjsopen/zrae056

Complications and adverse events in lymphadenectomy of the inguinal area: worldwide expert consensus

2024

Journal Article

Lymphatic expression of the proliferation marker Ki67 is linked to sentinel node positivity, recurrence and mortality in primary cutaneous melanoma

Tan, Samuel X., Chong, Sharene, Rowe, Casey, Galbraith, Jack, Dight, James, Zhou, Chenhao, Malt, Maryrose, Smithers, Bernard Mark and Khosrotehrani, Kiarash (2024). Lymphatic expression of the proliferation marker Ki67 is linked to sentinel node positivity, recurrence and mortality in primary cutaneous melanoma. Experimental Dermatology, 33 (3) e15041, 1-7. doi: 10.1111/exd.15041

Lymphatic expression of the proliferation marker Ki67 is linked to sentinel node positivity, recurrence and mortality in primary cutaneous melanoma

2024

Journal Article

iCare – a self-directed, interactive online program to improve health and wellbeing for people living with upper gastrointestinal or hepato-pancreato-biliary cancers, and their informal carers: the study protocol for a Phase II randomised controlled trial

Livingston, Patricia M., Winter, Natalie, Ugalde, Anna, Orellana, Liliana, Mikocka-Walus, Antonina, Jefford, Michael, Zalcberg, John, Orford, Neil, Hutchinson, Alison M., Barbour, Andrew, Kiss, Nicole, Smithers, Bernard Mark, Watson, David I., McCaffrey, Nikki and White, Victoria (2024). iCare – a self-directed, interactive online program to improve health and wellbeing for people living with upper gastrointestinal or hepato-pancreato-biliary cancers, and their informal carers: the study protocol for a Phase II randomised controlled trial. BMC Cancer, 24 (1) 144. doi: 10.1186/s12885-024-11861-2

iCare – a self-directed, interactive online program to improve health and wellbeing for people living with upper gastrointestinal or hepato-pancreato-biliary cancers, and their informal carers: the study protocol for a Phase II randomised controlled trial

2024

Journal Article

Novel Textbook Outcomes following emergency laparotomy: Delphi exercise

Naumann, David N., Bhangu, Aneel, Brooks, Adam, Martin, Matthew, Cotton, Bryan A., Khan, Mansoor, Midwinter, Mark J., Pearce, Lyndsay, Bowley, Douglas M., Holcomb, John B., Griffiths, Ewen A., Smithers, Mark (BEACON Collaborative group member) and BEACON Collaborative (2024). Novel Textbook Outcomes following emergency laparotomy: Delphi exercise. BJS Open, 8 (1) zrad145. doi: 10.1093/bjsopen/zrad145

Novel Textbook Outcomes following emergency laparotomy: Delphi exercise

2024

Journal Article

Automated scoring of tumour infiltrating lymphocytes informs risk of death from thin melanoma: a nested case-case study

Tan, Samuel X., Aung, Thazin N., Claeson, Magdalena, Acs, Balazs, Zhou, Chenhao, Brown, Susan, Lambie, Duncan, Baade, Peter D., Pandeya, Nirmala, Soyer, H. Peter, Smithers, B. Mark, Whiteman, David C., Rimm, David L. and Khosrotehrani, Kiarash (2024). Automated scoring of tumour infiltrating lymphocytes informs risk of death from thin melanoma: a nested case-case study. Journal of the American Academy of Dermatology, 90 (1), 179-182. doi: 10.1016/j.jaad.2023.09.026

Automated scoring of tumour infiltrating lymphocytes informs risk of death from thin melanoma: a nested case-case study

2023

Journal Article

pSTAT5 is associated with improved survival in patients with thick or ulcerated primary cutaneous melanoma

Tan, Samuel X., Chong, Sharene, Rowe, Casey, Claeson, Magdalena, Dight, James, Zhou, Chenhao, Rodero, Mathieu P., Malt, Maryrose, Smithers, B. Mark, Green, Adele C. and Khosrotehrani, Kiarash (2023). pSTAT5 is associated with improved survival in patients with thick or ulcerated primary cutaneous melanoma. Melanoma Research, 33 (6), 506-513. doi: 10.1097/cmr.0000000000000915

pSTAT5 is associated with improved survival in patients with thick or ulcerated primary cutaneous melanoma

2023

Journal Article

PHYSIO+++: protocol for a pilot randomised controlled trial assessing the feasibility of physiotherapist-led non-invasive ventilation for patients with hypoxaemia following abdominal surgery

Hackett, Claire, Denehy, Linda, Kruger, Peter, Ripley, Nina, Reid, Natasha, Smithers, B. Mark, Walker, Rachel M., Hope, Louise and Boden, Ianthe (2023). PHYSIO+++: protocol for a pilot randomised controlled trial assessing the feasibility of physiotherapist-led non-invasive ventilation for patients with hypoxaemia following abdominal surgery. BMJ Open, 13 (12) e078175, 1-10. doi: 10.1136/bmjopen-2023-078175

PHYSIO+++: protocol for a pilot randomised controlled trial assessing the feasibility of physiotherapist-led non-invasive ventilation for patients with hypoxaemia following abdominal surgery

2023

Journal Article

Prognosis of naevoid melanomas

Cook, Martin G., Grant, Megan, Sylvestre, Yvonne, Akhras, Victoria, Khosrotehrani, Kiarash, Hughes, Maria Celia B, Malt, Maryrose, Smithers, B. Mark, Massi, Daniela, De Giorgi, Vincenzo, Marais, Richard and Green, Adele C. (2023). Prognosis of naevoid melanomas. Pathology - Research and Practice, 251 154881, 154881. doi: 10.1016/j.prp.2023.154881

Prognosis of naevoid melanomas

2023

Journal Article

ctDNA: a promising biomarker for predicting recurrence in BRAF-negative melanoma patients

Aoude, Lauren G., Brosda, Sandra, Ng, Jessica, Lonie, James M., Belle, Clemence J., Patel, Kalpana, Koufariotis, Lambros T., Wood, Scott, Atkinson, Victoria, Smithers, B. Mark, Pearson, John V., Waddell, Nicola, Barbour, Andrew P. and Bonazzi, Vanessa F. (2023). ctDNA: a promising biomarker for predicting recurrence in BRAF-negative melanoma patients. Journal of Molecular Diagnostics, 25 (10), 771-781. doi: 10.1016/j.jmoldx.2023.06.014

ctDNA: a promising biomarker for predicting recurrence in BRAF-negative melanoma patients

Supervision

Availability

Professor Mark Smithers is:
Not available for supervision

Supervision history

Current supervision

  • Master Philosophy

    Retroperitoneal sarcoma: Impact of the patterns of care on patient outcomes in Queensland.

    Principal Advisor

    Other advisors: Professor Andrew Barbour

  • Master Philosophy

    Trends in the regional nodal management of cutaneous melanoma.

    Principal Advisor

    Other advisors: Professor Peter Soyer

  • Doctor Philosophy

    Utilising the Multi-Disciplinary Resources at Tertiary Centres to Improve Outcomes from Pancreatic Cancer

    Associate Advisor

    Other advisors: Dr David Cavallucci

  • Master Philosophy

    Factors Influencing Anastomotic Complications after Oesophagectomy

    Associate Advisor

Completed supervision

Media

Enquiries

Contact Professor Mark Smithers directly for media enquiries about:

  • Advanced endoscopic surgery
  • Cancer surgery
  • Endoscopic surgery
  • General surgery
  • Melanoma
  • Surgery - cancer
  • Surgery - oesophageal, gastric cancer
  • Surgery - upper GI
  • Upper GI surgery

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au